- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04926896
Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect
September 23, 2023 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
Clinical Randomized Controlled Study on the Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect
In this research, a new bone harvesting technique is introduced in order to find an iliac crest bone harvesting method for patients with less trauma, less postoperative pain in donor sites, and lower incidence of postoperative complications, so as to get ideal bone grafting materials at a small cost, enhance the effect of osteogenesis repair on bone defect or fusion site, and improve the operation quality.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Based on the domestic and foreign research on minimally invasive bone harvesting, we have developed a disposable battery-powered bone harvesting device that can be used for milling bone tissues.
Using this disposable battery-powered bone harvesting device, cancellous bone milling can be performed in a small bone hole with a diameter of 7.5 mm.
The morselized bone or bone chips it milled can be used for bone fusion at the desired site.
The technique adopts patented milling tool bit and electric drive, with high operation efficiency, so the surgery can be completed very quickly.
The bone trauma in the operation can be significantly reduced and the pain in the donor site can be greatly alleviating.
Moreover, the technique can obviously reduce the duration of bone harvesting and the cost of operating room.
In addition, significant reductions in postoperative pain will also be helpful to a range of clinical advantages and benefits, such as the average hospitalization days, and will be expected to benefit significantly in patients undergoing autologous bone harvesting.
Study Type
Interventional
Enrollment (Estimated)
336
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Li L Wanli, M.D.
- Phone Number: 13967116021
- Email: liwanli@furunmed.com
Study Contact Backup
- Name: Li L Hongmei
- Phone Number: 13857139616
- Email: lihongmei@furunmed.com
Study Locations
-
-
Zhe Jiang
-
Hangzhou, Zhe Jiang, China, 311100
- Recruiting
- Hangzhou Xinrun Medical Technology Co., Ltd.
-
Contact:
- Li L Wanli, M.D.
- Phone Number: 13967116021
- Email: liwanli@furunmed.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with clinical bone defects or need for bone fusion;
- Age 18 to 65, and gender is not limited;
- Informed consent has been signed.
Exclusion Criteria:
- Age less than 18 or greater than 65;
- Patients with severe deformities of the iliac bone or extensive defects of the iliac bone, which are not suitable for bone extraction;
- Patients with coagulation dysfunction;
- Patients who are unwilling to perform iliac bone extraction;
- BMI & lt; = 18.5 kg/m2;
- Patients with type I and type II diabetes;
- Osteoporosis(T & lt; = -2.5);
- Moderate and severe anemia(hemoglobin & lt; 9g/L) or hypoproteinemia(albumin & lt; 30g/L);
- Patients with malignant neoplasms; Patients with mental illness and those who are unconscious and unable to express themselves accurately.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Minimally invasive bone harvesting surgery
|
Minimally invasive bone harvesting surgery
|
Placebo Comparator: Traditional iliac crest bone harvesting surgery
|
The experimental group and the control group do not have special requirements; perform the surgery according to the normal operation methods of different sites.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the VAS score of pain in the donor site
Time Frame: 24 hours after the operation
|
the VAS score of pain in the donor site
|
24 hours after the operation
|
the comprehensive curative effect
Time Frame: 6 months after the operation
|
the healing rate of the bone graft site
|
6 months after the operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Yan Y Shigui, Professor, Chief Scientist
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2020
Primary Completion (Estimated)
September 21, 2024
Study Completion (Estimated)
December 21, 2024
Study Registration Dates
First Submitted
June 9, 2021
First Submitted That Met QC Criteria
June 14, 2021
First Posted (Actual)
June 15, 2021
Study Record Updates
Last Update Posted (Actual)
September 26, 2023
Last Update Submitted That Met QC Criteria
September 23, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2019-254
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Control Group
-
University of ValenciaNot yet recruitingControl Group | Training Group
-
Akdeniz UniversityCompletedControl Group | Acceledent Group
-
Beijing Normal UniversityCompleted
-
University of Witten/HerdeckeRecruitingControl Group | Experimental Group: Smartphone Use ReductionGermany
-
Arizona State UniversityCompletedMeditation | Control GroupUnited States
-
Philipps University Marburg Medical CenterCompletedControl Group | Experimental Group 1 (Video Personal Expert) | Experimental Group 2 (Video Factual Expert)Germany
-
Arizona State UniversityCompleted
-
Pitzer CollegeRecruitingOMI, OMI+, Control GroupUnited States
-
Oregon State UniversityRecruiting
-
Vanderbilt UniversityUniversity of California, IrvineCompletedCondition 1 - Educational Condition (Educational Book Group) | Condition 2 - Non-educational Condition (Non-educational Book Group) | Condition 3 - Control Condition (No-book Group)United States
Clinical Trials on Minimally invasive bone harvesting surgery
-
Istituto Clinico HumanitasFondazione Umberto VeronesiRecruiting
-
University of OuluRecruitingEndometriosis | Surgery | Deep EndometriosisFinland
-
National Taiwan University HospitalCompletedColorectal Cancer | AdhesionTaiwan
-
October 6 UniversityCompleted
-
Tianjin Medical University Cancer Institute and...Harvard Medical School (HMS and HSDM); M.D. Anderson Cancer Center; Massachusetts... and other collaboratorsEnrolling by invitation
-
Yarmouk UniversityCompletedMinimally Invasive Surgery | Hydatid Disease | Spleen-Preserving Surgery | Echinococcus Granulosus InfectionJordan
-
Hospital del MarEnrolling by invitationGallbladder CancerSpain
-
The European Research Group on Periodontology (ERGOPerio)Completed
-
University of Illinois at ChicagoRecruiting
-
Yonsei UniversityRecruiting